Unknown PHASE4 INTERVENTIONAL NCT01184599

A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy

Sponsor: Kagawa University

Conditions Glomerulonephritis, IGA Hypertension

Interventions aliskiren

Updated 5 times since 2017 Last updated: Jun 23, 2011 Started: Jun 30, 2010 Primary completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Glomerulonephritis, IGA and Hypertension, this trial is ongoing. The trial is conducted by Kagawa University and has accumulated 5 data snapshots since 2010. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kagawa University

Data source: Kagawa University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fukuoka, Japan
• Osaka, Japan